Codexis, Inc.

CDXS

$2.47

Name : Codexis, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $224,514,528.00

EPSttm : -0.35

Codexis, Inc.

$2.47

5.18%

$0.135

CDXS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.39

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

0.01

EPS Last/This Y

0.15

EPS This/Next Y

-0.02

Price

2.47

Target Price

6.58

Analyst Recom

1.57

Performance Q

99.19

Upside

-610.1%

Beta

2.47

Ticker: CDXS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	CDXS	2.65	0.02	0.00	3399
2026-05-12	CDXS	2.55	0.02	0.00	3398
2026-05-13	CDXS	2.51	0.02	0.01	3396
2026-05-14	CDXS	2.58	0.02	0.00	3326
2026-05-15	CDXS	2.45	0.02	0.07	3334
2026-05-18	CDXS	2.54	0.04	14.36	1839
2026-05-19	CDXS	2.46	0.16	0.02	2047
2026-05-20	CDXS	2.57	0.15	0.04	2073
2026-05-21	CDXS	2.53	0.15	0.00	2094
2026-05-22	CDXS	2.49	0.17	0.33	1924
2026-05-26	CDXS	2.6	0.17	11.83	1930
2026-05-27	CDXS	2.64	0.21	0.85	2002
2026-05-28	CDXS	2.74	0.20	0.13	1985
2026-05-29	CDXS	2.77	0.20	0.10	1977
2026-06-02	CDXS	2.69	0.20	0.03	2012
2026-06-03	CDXS	2.71	0.19	0.09	2079
2026-06-04	CDXS	2.8	0.19	0.00	2083
2026-06-05	CDXS	2.55	0.16	1.55	2446
2026-06-08	CDXS	2.61	0.18	2.00	2513
2026-06-09	CDXS	2.47	0.18	0.00	2516
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	CDXS	2.65	58.0	-	-0.37
2026-05-12	CDXS	2.55	34.4	-	-0.37
2026-05-13	CDXS	2.50	34.4	-	-0.37
2026-05-14	CDXS	2.58	34.4	-	-0.37
2026-05-15	CDXS	2.45	34.4	-	-0.37
2026-05-18	CDXS	2.54	6.3	-	-0.46
2026-05-19	CDXS	2.46	6.3	-	-0.46
2026-05-20	CDXS	2.58	6.3	-	-0.46
2026-05-21	CDXS	2.53	6.3	-	-0.46
2026-05-22	CDXS	2.49	6.3	-	-0.46
2026-05-26	CDXS	2.60	6.3	-	-0.46
2026-05-27	CDXS	2.65	6.3	-	-0.46
2026-05-28	CDXS	2.74	6.3	-	-0.46
2026-05-29	CDXS	2.77	6.3	-	-0.46
2026-06-01	CDXS	2.67	25.0	-	-0.35
2026-06-02	CDXS	2.69	25.0	-	-0.35
2026-06-03	CDXS	2.71	25.0	-	-0.35
2026-06-04	CDXS	2.80	25.0	-	-0.35
2026-06-05	CDXS	2.54	25.0	-	-0.35
2026-06-08	CDXS	2.60	25.0	-	-0.35
2026-06-09	CDXS	2.47	25.0	-	-0.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	CDXS	-15.70	2.45	7.46
2026-05-12	CDXS	-16.76	2.45	5.56
2026-05-13	CDXS	-8.05	2.45	5.56
2026-05-14	CDXS	-8.03	2.45	5.56
2026-05-15	CDXS	-5.55	2.45	5.56
2026-05-18	CDXS	-5.55	-2.52	5.56
2026-05-19	CDXS	-5.55	-2.52	5.56
2026-05-20	CDXS	-5.55	-2.52	5.56
2026-05-21	CDXS	-5.55	-2.52	5.56
2026-05-22	CDXS	-5.55	-2.52	5.56
2026-05-26	CDXS	-5.43	-0.50	5.56
2026-05-27	CDXS	-5.43	-0.50	5.56
2026-05-28	CDXS	-5.43	-0.50	4.39
2026-05-29	CDXS	-5.43	-0.50	4.39
2026-06-02	CDXS	-0.31	-1.18	4.39
2026-06-03	CDXS	-0.31	-1.18	4.39
2026-06-04	CDXS	-0.31	-1.18	4.39
2026-06-05	CDXS	-0.31	-1.18	4.39
2026-06-08	CDXS	-0.31	-1.14	4.39
2026-06-09	CDXS	-0.31	-1.14	4.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.1

Avg. EPS Est. Current Quarter

-0.12

Avg. EPS Est. Next Quarter

-0.09

Insider Transactions

-0.31

Institutional Transactions

-1.14

Beta

2.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.1

Max Drawdown 5-Year %

-97.7

Target Price

6.58

P/E

Forward P/E

PEG

P/S

2.88

P/B

5.19

P/Free Cash Flow

EPS

-0.36

Average EPS Est. Cur. Y

-0.35

EPS Next Y. (Est.)

-0.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-40.96

Relative Volume

0.49

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-85.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.04

EBIT Estimation

◆ CDXS Healthcare

$2.47

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

15/25

Volume

11/15

Valuation

10/20

TP/AR

1/10

Options

8/10

RSI

45.6

Range 1M

20.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

21/30

Estimates

1/20

Inst/Vol

4/15

Options

6/10

EPS Yr

22.7%

EPS NY

25.5%

52W%

52.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +166.4% upside

Quality

7/30

Valuation

16/30

Growth

18/25

Stability

4/10

LT Trend

0/5

Upside

+166.4%

Quality

Codexis, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 146

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

CDXS

Latest News

—

Caricamento notizie per CDXS…

stock quote shares CDXS – Codexis, Inc. Stock Price stock today

news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CDXS – Codexis, Inc. yahoo finance google finance

stock history CDXS – Codexis, Inc. invest stock market

stock prices CDXS premarket after hours

ticker CDXS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CDXS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y